Innovating Works

MERCK HEALTHCARE KGAA

Desconocido
VICT3R: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research VICT3R, a public-private partnership running under the European Innovative Health Initiative, aims to significantly reduce the number of ani...
2024-07-26 - 2028-02-29 | Financiado
trainLSE: Interdisciplinary and intersectoral doctoral training programme at the Technische Universität Darmst... MERCK HEALTHCARE KGAA participó en un HORIZON EUROPE HORIZON-MSCA-2022-COFUND-01 "The presented programme ""trainLSE: Interdisciplinary and intersectoral doctoral training programme at the Technische Universität Darmstadt...
2023-09-22 - 2029-03-31 | Financiado
CANCERNA: RNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPY MERCK HEALTHCARE KGAA participó en un HORIZON EUROPE HORIZON-HLTH-2021-TOOL-06 In the past five years, RNA therapeutics have witnessed a true revolution. Several RNA-based therapies have been approved for the treatment...
2022-05-19 - 2025-05-31 | Financiado
ALLODD: Allostery in Drug Discovery MERCK HEALTHCARE KGAA participó en un H2020 H2020-MSCA-ITN-2020 Most current drugs are designed to bind directly to the primary active sites (also known as orthosteric sites) of their biological targets....
2021-05-28 - 2025-08-31 | Financiado
AGePOP: Drug Absorption in Geriatric Patients and Older People a training network innovating drug developme... MERCK HEALTHCARE KGAA participó en un H2020 H2020-MSCA-ITN-2020 The advanced age population (>65y) makes up ~20% of the total population in Europe, is the main carrier of chronic diseases and the major en...
2020-08-18 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.